chr6-161034296-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005922.4(MAP3K4):​c.190C>T​(p.Pro64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000563 in 1,613,788 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P64H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 2 hom. )

Consequence

MAP3K4
NM_005922.4 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.89

Publications

2 publications found
Variant links:
Genes affected
MAP3K4 (HGNC:6856): (mitogen-activated protein kinase kinase kinase 4) The central core of each mitogen-activated protein kinase (MAPK) pathway is a conserved cascade of 3 protein kinases: an activated MAPK kinase kinase (MAPKKK) phosphorylates and activates a specific MAPK kinase (MAPKK), which then activates a specific MAPK. While the ERK MAPKs are activated by mitogenic stimulation, the CSBP2 and JNK MAPKs are activated by environmental stresses such as osmotic shock, UV irradiation, wound stress, and inflammatory factors. This gene encodes a MAPKKK, the MEKK4 protein, also called MTK1. This protein contains a protein kinase catalytic domain at the C terminus. The N-terminal nonkinase domain may contain a regulatory domain. Expression of MEKK4 in mammalian cells activated the CSBP2 and JNK MAPK pathways, but not the ERK pathway. In vitro kinase studies indicated that recombinant MEKK4 can specifically phosphorylate and activate PRKMK6 and SERK1, MAPKKs that activate CSBP2 and JNK, respectively but cannot phosphorylate PRKMK1, an MAPKK that activates ERKs. MEKK4 is a major mediator of environmental stresses that activate the CSBP2 MAPK pathway, and a minor mediator of the JNK pathway. Several alternatively spliced transcripts encoding distinct isoforms have been described. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003989309).
BP6
Variant 6-161034296-C-T is Benign according to our data. Variant chr6-161034296-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 3898197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 430 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005922.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K4
NM_005922.4
MANE Select
c.190C>Tp.Pro64Ser
missense
Exon 2 of 27NP_005913.3Q9Y6R4-1
MAP3K4
NM_001301072.2
c.190C>Tp.Pro64Ser
missense
Exon 2 of 27NP_001288001.2F5H538
MAP3K4
NM_006724.4
c.190C>Tp.Pro64Ser
missense
Exon 2 of 26NP_006715.3Q9Y6R4-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K4
ENST00000392142.9
TSL:1 MANE Select
c.190C>Tp.Pro64Ser
missense
Exon 2 of 27ENSP00000375986.4Q9Y6R4-1
MAP3K4
ENST00000366919.6
TSL:1
c.190C>Tp.Pro64Ser
missense
Exon 2 of 26ENSP00000355886.2Q9Y6R4-2
MAP3K4
ENST00000490904.6
TSL:1
n.190C>T
non_coding_transcript_exon
Exon 2 of 28ENSP00000446303.1F5H1X6

Frequencies

GnomAD3 genomes
AF:
0.00283
AC:
431
AN:
152126
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0100
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000824
AC:
207
AN:
251082
AF XY:
0.000567
show subpopulations
Gnomad AFR exome
AF:
0.0110
Gnomad AMR exome
AF:
0.000579
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000980
GnomAD4 exome
AF:
0.000328
AC:
479
AN:
1461544
Hom.:
2
Cov.:
31
AF XY:
0.000267
AC XY:
194
AN XY:
727076
show subpopulations
African (AFR)
AF:
0.0111
AC:
370
AN:
33470
American (AMR)
AF:
0.000626
AC:
28
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000315
AC:
35
AN:
1111780
Other (OTH)
AF:
0.000745
AC:
45
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
430
AN:
152244
Hom.:
1
Cov.:
32
AF XY:
0.00262
AC XY:
195
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00994
AC:
413
AN:
41534
American (AMR)
AF:
0.000654
AC:
10
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68014
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00116
Hom.:
1
Bravo
AF:
0.00343
ESP6500AA
AF:
0.00931
AC:
41
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000997
AC:
121
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
7.1
DANN
Benign
0.18
DEOGEN2
Benign
0.034
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.79
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.55
N
PhyloP100
1.9
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.30
N
REVEL
Benign
0.11
Sift
Benign
0.67
T
Sift4G
Benign
0.18
T
Polyphen
0.0
B
Vest4
0.12
MVP
0.16
MPC
0.29
ClinPred
0.00019
T
GERP RS
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.024
gMVP
0.072
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147981479; hg19: chr6-161455328; COSMIC: COSV62333014; API